Description
PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. Researchers use it as a non-selective melanocortin receptor agonist.
In cultured cells and laboratory animals, work has focused on melanocortin receptor activation, centrally mediated behavior, and second-messenger signaling. Its defined receptor engagement makes it a reference point for melanocortin research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.